| Model Number |
7800RR32 |
| Medical Device Problem Code |
Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Code |
Mitral Valve Insufficiency/ Regurgitation (4451)
|
| Date of Event |
10/09/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that during the implant of this 32mm simuform sr heart ring, it was explanted and replaced with a competitors product.The reason for the replacement was reported as mitral regurgitation (mr).No additional adverse patient effects were reported.
|
| |
|
Event or Problem Description
|
|
Additional information was received that reported the annuloplasty ring was fully sutured and tested prior to removal.The replacement device was also confirmed to be the same 32mm size of the annuloplasty ring.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b.5: event description medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b.5: event description medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that reported the severity of mitral regurgitation as moderate to severe.It was also noted that the replacement device was a mitral valve repair product.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|